Prosecution Insights
Prosecution Insights
10 pending office actions • 2 clients • 10 examiners • 7 art units • 0 of 10 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (50%) |
| §112 only | 1 (10%) |
| Double-patenting only | 1 (10%) |
| Double-patenting + other | 1 (10%) |
| No statute on record | 2 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, TYLER J | 1 | 92.1% | +6.9% |
| POON, KING Y | 1 | 57.1% | +50.0% |
| CHEN, STACY BROWN | 1 | 65.9% | +40.5% |
| GILL, RACHEL B | 1 | 65.5% | +28.0% |
| TSAY, MARSHA M | 1 | 45.7% | +52.4% |
| BUNNER, BRIDGET E | 1 | 64.2% | +19.8% |
| KANE, TREVOR LOGAN | 1 | 70.2% | +49.3% |
| BLUMEL, BENJAMIN P | 1 | 70.7% | +30.7% |
| MONAHAN, MEGAN ELIZABETH | 1 | 58.1% | +16.7% |
| SPANGLER, JOSEPH RANKIN | 1 | 37.9% | +63.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17938752 | De novo designed protein homodimers containing tunable symmetric pockets | TSAY, MARSHA M | 169d overdue |
| 18359154 | SELF-ASSSEMBLING NANOSTRUCTURE VACCINES | GILL, RACHEL B | 14d |
| 17434832 | Precise Gene Activation Via Novel Designed Proteins Mediating Epigenetic Remodeling | SPANGLER, JOSEPH RANKIN | 20d |
| 17760180 | POLYPEPTIDES AND THEIR USE | BLUMEL, BENJAMIN P | 21d |
| 18708734 | Camera Probe Navigation within Cavity | POON, KING Y | — |
| 18360190 | Glycoengineered protein nanoparticles and uses thereof | CHEN, STACY BROWN | — |
| 17907372 | DESIGNED ANTIBODY-BOUND NANOPARTICLES | BUNNER, BRIDGET E | — |
| 17931704 | COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE | KANE, TREVOR LOGAN | — |
| Client (Assignee) | Pending OAs |
|---|---|
| University of Washington | 9 |
| University of California | 1 |
| Art Unit | Apps |
|---|---|
| 1671 | 2 |
| 1656 | 2 |
| 2617 | 1 |
| 1672 | 1 |
| 1647 | 1 |
| 1657 | 1 |
| 3795 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18868532 | Untitled | UNIVERSITY OF WASHINGTON | LEE, TYLER J | — | Non-Final OA | — | Pending | ||
| 18708734 | Camera Probe Navigation within Cavity | UNIVERSITY OF WASHINGTON | POON, KING Y | 2617 | §103 | Non-Final OA | — | Pending | May 09, 2024 |
| 18360190 | Glycoengineered protein nanoparticles and uses thereof | UNIVERSITY OF WASHINGTON | CHEN, STACY BROWN | 1672 | §112 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18359154 | SELF-ASSSEMBLING NANOSTRUCTURE VACCINES | UNIVERSITY OF WASHINGTON | GILL, RACHEL B | 1671 | §103 | Final Rejection | 14d | Pending | Jul 26, 2023 |
| 17938752 | De novo designed protein homodimers containing tunable symmetric pockets | UNIVERSITY OF WASHINGTON | TSAY, MARSHA M | 1656 | — | Non-Final OA | 169d overdue | Pending | Oct 07, 2022 |
| 17907372 | DESIGNED ANTIBODY-BOUND NANOPARTICLES | UNIVERSITY OF WASHINGTON | BUNNER, BRIDGET E | 1647 | DPOther | Final Rejection | — | Pending | Sep 26, 2022 |
| 17931704 | COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE | The Regents of the University of California | KANE, TREVOR LOGAN | 1657 | DP | Non-Final OA | — | Pending | Sep 13, 2022 |
| 17760180 | POLYPEPTIDES AND THEIR USE | UNIVERSITY OF WASHINGTON | BLUMEL, BENJAMIN P | 1671 | §103 | Non-Final OA | 21d | Pending | Aug 04, 2022 |
| 17595946 | Endoscope Steering Mechanism with Everted Tube Introducer | UNIVERSITY OF WASHINGTON | MONAHAN, MEGAN ELIZABETH | 3795 | §103 | Final Rejection | — | Pending | Nov 30, 2021 |
| 17434832 | Precise Gene Activation Via Novel Designed Proteins Mediating Epigenetic Remodeling | UNIVERSITY OF WASHINGTON | SPANGLER, JOSEPH RANKIN | 1656 | §103 | Final Rejection | 20d | Pending | Aug 30, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial